共 244 条
[1]
Meyer A(2015)Incidence and prevalence of inflammatory myopathies: a systematic review Rheumatology (Oxford) 54 50-63
[2]
Meyer N(1975)Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 344-347
[3]
Schaeffer M(1975)Polymyositis and dermatomyositis (second of two parts) N Engl J Med 292 403-407
[4]
Gottenberg J-E(2018)Autoantibodies in myositis Nat Rev Rheumatol 14 290-302
[5]
Geny B(2014)Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review Autoimmun Rev 13 367-371
[6]
Sibilia J(2018)Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis Arthritis Res Ther 20 158-298
[7]
Bohan A(1999)Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis Arthritis Rheum 42 291-843
[8]
Peter JB(2009)Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies Ann Rheum Dis 68 836-999
[9]
Bohan A(2016)Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab Rheumatol (United Kingdom) 55 991-36
[10]
Peter JB(2017)Rituximab in the treatment of inflammatory myopathies: a review Rheumatology. 56 26-596